Effektivnost' primeneniya preparata Lavenum® u bol'nykh varikoznoy bolezn'yu, perenesshikh venektomiyu nizhnikh konechnostey
- Authors: Luneva S.N1, Stogov M.V1, Barykin D.Y.1, Men'shikova T.I1, Trofimova E.V1, Tushina N.V1
-
Affiliations:
- Issue: No 10 (2013)
- Pages: 100-103
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/281955
- ID: 281955
Cite item
Abstract
Full Text
About the authors
S. N Luneva
Email: Luneva s@mail.ru
M. V Stogov
D. Yu Barykin
T. I Men'shikova
E. V Trofimova
N. V Tushina
References
- Эмануэл В.Л., Гриценко В.В. Лабораторный контроль антикоагулянтной терапии у хирургических больных. Методические рекомендации. СПб., 2002.
- Шилов А.М., Мельник М.В. Тиклин в профилактике и лечении сердечнососудистых заболеваний // Рос. мед. вести 2003. № 4. C. 42.
- Шиффман Ф.Д. Патофизиология крови. Пер. с англ. М., 2000. C. 191-82.
- Butchart EG, Bodnar E. Trombosis, embolism and bliding. London, ICR Pablisher 1992: 123-72.
- Mehta S, Ysuf S, Peters R, et all. Effects of pretreatment with clopidogrel and aspirin fallowed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527.
- The Assessment of the Safety and Efficacy of a New Thrombolytc Regimen. (ASSENT) -3 investigators. Efficacy and safety of tenecteplase in comination with enoxaparine, aboximab or unfractionated heparin: the ASSENT - 3 randomised trial in acute myocardial infarction. Lancet 2001; 358:605.
- Основы клинической флебологии / Под ред. Ю.Л. Шевченко, Ю.М. Стойко, М.И. Лыткина. М., 2005. 246 c.
- Комов В.П. Биохимия. М., 2004. 638 с.
- Nighttingel SL. Appropriate use of low molecular weight heparins (LMWH). JAMA 2003;270:1672-76.